Trials / Terminated
TerminatedNCT02706769
Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Pain
A Double-blind Randomised Parallel Group Trial of Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Related Pain
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
National guidelines advocate the use of paracetamol in conjunction with strong opioids for cancer pain, despite a lack of evidence for its efficacy. Work is needed to examine the analgesic benefit of paracetamol in this large patient group. The investigators aim to establish if paracetamol in combination with strong opioids provides superior analgesia for cancer related pain over strong opioids alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Study medication contains blinded placebo |
| DRUG | Paracetamol | Study medication contains blinded paracetamol |
Timeline
- Start date
- 2016-11-25
- Primary completion
- 2018-09-04
- Completion
- 2019-05-01
- First posted
- 2016-03-11
- Last updated
- 2019-09-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02706769. Inclusion in this directory is not an endorsement.